(Q46350273)

21 December 2017

title

Suppression of renin-angiotensin gene expression in the kidney by paricalcitol (English)

1 reference

21 December 2017

author name string

Michael Freundlich

1

1 reference

21 December 2017

Yasmir Quiroz

2

1 reference

21 December 2017

Zhongyi Zhang

3

1 reference

21 December 2017

Yan Zhang

4

1 reference

21 December 2017

Yanauri Bravo

5

1 reference

21 December 2017

Jose R Weisinger

6

1 reference

21 December 2017

Yan Chun Li

7

1 reference

21 December 2017

Bernardo Rodriguez-Iturbe

8

1 reference

21 December 2017

language of work or name

English

0 references

publication date

27 August 2008

1 reference

21 December 2017

published in

Kidney International

1 reference

21 December 2017

volume

74

1 reference

21 December 2017

issue

11

1 reference

21 December 2017

page(s)

1394-1402

1 reference

21 December 2017

https://scigraph.springernature.com/pub.10.1038/ki.2008.408

exact match

0 references

cites work

National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Economic evaluation and end-stage renal disease: from basics to bedside

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Renin-angiotensin-aldosterone system and progression of renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Retarding the progression of renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Tubulointerstitial damage and progression of renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Vitamin D treatment in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Mechanism of vitamin D action and its regulation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Reduction of blood pressure during long-term treatment with active vitamin D (alphacalcidol) is dependent on plasma renin activity and calcium status. A double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

22-Oxacalcitriol prevents progressive glomerulosclerosis without adversely affecting calcium and phosphorus metabolism in subtotally nephrectomized rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Different effects of 22-oxacalcitriol and calcitriol on the course of experimental chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Treatment with 1,25-dihydroxyvitamin D3 preserves glomerular slit diaphragm-associated protein expression in experimental glomerulonephritis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Calcium Metabolism in Early Chronic Renal Failure: Implications for the Pathogenesis of Hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Antiproteinuric effect of oral paricalcitol in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Inhibitory effect of 1 alpha,25-dihydroxyvitamin D3 on the growth of the renal carcinoma cell line

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

1,25-Dihydroxyvitamin D3decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Early treatment with cGMP phosphodiesterase inhibitor ameliorates progression of renal damage

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Systemic cardiovascular disease in uremic rats induced by 1,25(OH)2D3.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Pathophysiological mechanisms of salt-dependent hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Add-on anti-TGF-beta antibody to ACE inhibitor arrests progressive diabetic nephropathy in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

TGF-beta signaling in vascular fibrosis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Renal angiotensin II concentration and interstitial infiltration of immune cells are correlated with blood pressure levels in salt-sensitive hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Renal interstitial fluid concentrations of angiotensins I and II in anesthetized rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Differential inhibition of renin mRNA expression by paricalcitol and calcitriol in C57/BL6 mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy. Implications for the pathogenesis of tubulointerstitial fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Cellular mechanism of renin release

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

High calcium diet down-regulates kidney angiotensin-converting enzyme in experimental renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Receptor-mediated actions of renin and prorenin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Renal expression of COX-2, ANG II, and AT1 receptor in remnant kidney: strong renoprotection by therapy with losartan and a nonsteroidal anti-inflammatory

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Increased expression of vascular endothelial growth factor in kidney leads to progressive impairment of glomerular functions.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Pathophysiological role of vascular endothelial growth factor in the remnant kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Angiotensin II stimulates the synthesis of vascular endothelial growth factor through the p38 mitogen activated protein kinase pathway in cultured mouse podocytes.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Paricalcitol versus calcitriol treatment for hyperparathyroidism in pediatric hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Overload proteinuria is followed by salt-sensitive hypertension caused by renal infiltration of immune cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Early and sustained inhibition of nuclear factor-kappaB prevents hypertension in spontaneously hypertensive rats.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Evolution of renal interstitial inflammation and NF-kappaB activation in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Chronic exposure to low doses of lead results in renal infiltration of immune cells, NF-kappaB activation, and overexpression of tubulointerstitial angiotensin II.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

1,25-Dihydroxyvitamin D3 targeting of NF-kappaB suppresses high glucose-induced MCP-1 expression in mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Extraction and analysis of diagnostically useful proteins from formalin-fixed, paraffin-embedded tissue sections

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Melatonin ameliorates oxidative stress, inflammation, proteinuria, and progression of renal damage in rats with renal mass reduction.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.408

7 January 2021

Identifiers

DOI

10.1038/KI.2008.408

1 reference

21 December 2017

PubMed ID

18813285

1 reference

21 December 2017